A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).
This study has been completed.
Sponsor:
Abbott
Information provided by:
Abbott
ClinicalTrials.gov Identifier:
NCT01021358
First received: November 25, 2009
Last updated: December 16, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |